The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer

Table 4 Correlation between the number of mature dendritic cells and clinicopathological characteristics of patients

Variable	Islets + Stroma			Islets			Stroma
	< median	≥ median	P	< median	≥ median	P	< median	≥ median	P
Tumor stage:
I-II	21	34	0.012	23	32	0.107	22	33	0.044
III-IV	28	16		26	18		27	17
Histology
Adenocarcinoma	30	15	0.002	27	18	0.070	27	18	0.070
Non-adenocarcinoma	19	35		22	32		22	32
Tumor grade
Well to moderate differentiation	21	29	0.861	23	27	0.647	26	24	0.066
Poor differentiation	12	18		12	18		9	21
Lymph node metastasis
No	23	36	0.014	24	35	0.041	25	34	0.103
Yes	26	14		25	15		24	16

ISSN: 1471-2407